Hawkins Matthew J. sold $1.6M of WAY

Hawkins Matthew J. (Chief Executive Officer) sold 70,000 shares of Waystar Holding Corp. (WAY) at an average of $23.06 ($23.02–$23.09, $1.61M total) across 2 trades over 2026-07-15 to 2026-07-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hawkins Matthew J.
Published Jul 17, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WAY
Neutral
high confidence
Mentioned
$WAY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WAYNeutralLow
01

Why it matters

The newest information is the specific sale size, price range, and that it occurred under a 10b5-1 plan; it mainly informs sentiment and positioning rather than fundamentals.

02

Market read

A newly filed insider sale can cause short-term sentiment noise, but the 10b5-1 framing reduces interpretive value.

03

What to watch

Traders may over-weight insider sales; without changes to guidance, contracts, or financial results, the signal is typically weak.

Relevance 5/10Novelty 5/10Timing: after-hours/next-session read-through from a newly filed SEC Form 4 (filed 2026-07-17)

Background

The article is an SEC Form 4 insider transaction disclosure for Waystar Holding Corp.

Company-level read

Ticker impact

$WAYNeutralHigh confidence
Context

Waystar CEO Matthew J. Hawkins filed a Form 4 selling 70,000 shares in open-market trades for about $1.61M under a 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a routine insider transaction with a pre-arranged 10b5-1 plan, and the article provides no accompanying operational, financial, or regulatory developments.

Market effects

Minimal; insider sale at one company does not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Waystar Holding Corp.

    Subject of the Form 4 insider sale by its CEO.

  • Matthew J. Hawkins

    CEO and director who sold 70,000 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WAYHighAI 8/10

Why is Waystar stock sliding today?

Waystar Holding Corp (WAY) stock fell 4.1% in pre-market trading after Q3 earnings. Revenue rose 21% YoY to $325.6M, and adjusted EPS of $0.44 beat estimates. However, full-year 2026 revenue guidance missed expectations, with a midpoint of $1.282B below the $1.29B consensus. Analysts raised price targets but cited concerns over Q4 growth deceleration.

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.